![]() |
市场调查报告书
商品编码
1701506
生医材料市场规模、份额及成长分析(按类型、应用和地区)-2025-2032 年产业预测Biomaterials Market Size, Share, and Growth Analysis, By Type (Metallic Biomaterials, Polymeric Biomaterials), By Application (Orthopedic, Cardiovascular), By Region - Industry Forecast 2025-2032 |
2023 年生医材料市场规模价值 1,756 亿美元,预计将从 2024 年的 1991.3 亿美元成长到 2032 年的 5,445.6 亿美元,预测期内(2025-2032 年)的复合年增长率为 13.4%。
由于人口老化、心臟病和关节问题数量的增加、医疗技术的进步以及公众对植入设备的认识不断提高,全球生医材料市场正在经历显着增长。政府对生医材料研发的支持以及消费者对生医材料认识的提高也促进了市场的扩张。然而,相容性问题和生物材料植入高成本挑战可能会阻碍其发展。然而,用于移植的去细胞真皮基质和氢支架等新兴技术以及神经病学、创伤治疗和整形外科领域的创新产品预计将创造丰厚的机会。植入式生医材料的主要目标是最大限度地减少不良免疫反应,同时增强生物功能,最终解决多个学科的各种病症。
Biomaterials Market size was valued at USD 175.6 billion in 2023 and is poised to grow from USD 199.13 billion in 2024 to USD 544.56 billion by 2032, growing at a CAGR of 13.4% during the forecast period (2025-2032).
The global biomaterials market is experiencing significant growth driven by an aging population, increasing heart disease and joint issues, advancements in healthcare technology, and heightened public awareness of implanted devices. Government support for biomaterials R&D and greater consumer understanding of these products further contribute to market expansion. However, challenges such as compatibility issues and high costs of biomaterial implants may hinder growth. Nevertheless, emerging technologies, including decellularized dermal matrixes for grafting and hydrogen scaffolding, along with innovative products in neurology, wound healing, and plastic surgery, are expected to create lucrative opportunities. The primary aim of implantable biomaterials is to minimize adverse immune responses while enhancing biological function, ultimately addressing various medical conditions across multiple disciplines.
Top-down and bottom-up approaches were used to estimate and validate the size of the Biomaterials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Biomaterials Market Segments Analysis
Global Biomaterials Market is segmented by Type, Application and region. Based on Type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials and Other Natural Biomaterials. Based on Application, the market is segmented into Orthopedic, Cardiovascular, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System, Urinary and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Biomaterials Market
The growing demand for biomaterials in wound healing and plastic surgery significantly drives the biomaterials market. These innovative materials are widely utilized for various applications, including the implantation, reconstruction, and healing of burns, as well as addressing holes in the body and soft tissue injuries. Their ability to facilitate natural and safe recovery makes them essential in medical procedures. As healthcare professionals increasingly recognize the advantages of biomaterial-based products, the expansion of their use in cosmetic and reconstructive surgeries fuels market growth. This trend underscores the pivotal role biomaterials play in advancing medical treatments and improving patient outcomes.
Restraints in the Biomaterials Market
Orthopedic injuries and associated disorders result in significant impairment and suffering, representing a critical concern for global public health. These conditions often necessitate surgical interventions that involve the use of medical devices, which can be categorized as long-term, short-term, or biodegradable. Such procedures require the integration of various natural or synthetic biomaterials to effectively repair or replace essential tissues, including ligaments, tendons, cartilage, and bone. The continued reliance on these devices highlights the crucial role of biomaterials in addressing complex orthopedic challenges, yet underscores the pressing need to enhance their effectiveness and reduce complications in clinical settings.
Market Trends of the Biomaterials Market
The global biomaterials market is experiencing a significant upward trend driven by the rising demand for biodegradable materials, particularly in medical applications such as tissue engineering, wound healing, and drug delivery systems. These innovative materials are gaining preference due to their ability to safely degrade within the human body, minimizing the need for additional surgical interventions and enhancing patient recovery. As healthcare providers and patients increasingly prioritize sustainable and biocompatible options, the push towards biodegradable biomaterials is expected to accelerate. This shift not only reflects a commitment to improved health outcomes but also aligns with growing environmental concerns, further solidifying biodegradable biomaterials' relevance in the market.